BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $378,000 | -59.5% | 2,500 | -60.9% | 0.04% | -57.0% |
| Q2 2022 | $933,000 | -22.8% | 6,400 | -37.3% | 0.09% | -9.5% |
| Q1 2022 | $1,209,000 | -15.2% | 10,200 | -1.4% | 0.10% | -14.4% |
| Q4 2021 | $1,426,000 | -2.7% | 10,350 | -1.9% | 0.11% | -9.8% |
| Q3 2021 | $1,466,000 | +27.9% | 10,550 | -10.6% | 0.12% | +35.2% |
| Q2 2021 | $1,146,000 | +74.7% | 11,800 | +22.9% | 0.09% | +59.6% |
| Q1 2021 | $656,000 | +50.1% | 9,600 | +88.2% | 0.06% | +35.7% |
| Q4 2020 | $437,000 | +113.2% | 5,100 | +82.1% | 0.04% | +68.0% |
| Q2 2020 | $205,000 | – | 2,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |